These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18284469)

  • 21. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
    Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
    Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR
    Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
    Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression in cytotoxic T lymphocytes of a single-chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma.
    Darcy PK; Kershaw MH; Trapani JA; Smyth MJ
    Eur J Immunol; 1998 May; 28(5):1663-72. PubMed ID: 9603473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.
    Groh V; Wu J; Yee C; Spies T
    Nature; 2002 Oct; 419(6908):734-8. PubMed ID: 12384702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
    Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
    J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.
    Diefenbach A; Jensen ER; Jamieson AM; Raulet DH
    Nature; 2001 Sep; 413(6852):165-71. PubMed ID: 11557981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
    Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NKG2D is a costimulatory receptor for human naive CD8+ T cells.
    Maasho K; Opoku-Anane J; Marusina AI; Coligan JE; Borrego F
    J Immunol; 2005 Apr; 174(8):4480-4. PubMed ID: 15814668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
    Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer.
    Wu JD; Higgins LM; Steinle A; Cosman D; Haugk K; Plymate SR
    J Clin Invest; 2004 Aug; 114(4):560-8. PubMed ID: 15314693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
    Song H; Kim J; Cosman D; Choi I
    Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MHC class I chain-related molecules induced on monocytes by IFN-gamma promote NK cell activation.
    Wang H; Ruan Z; Wang Y; Han J; Fu X; Zhao T; Yang D; Xu W; Yang Z; Wang L; Chen Y; Wu Y
    Mol Immunol; 2008 Mar; 45(6):1548-56. PubMed ID: 18062910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.
    Carbone E; Neri P; Mesuraca M; Fulciniti MT; Otsuki T; Pende D; Groh V; Spies T; Pollio G; Cosman D; Catalano L; Tassone P; Rotoli B; Venuta S
    Blood; 2005 Jan; 105(1):251-8. PubMed ID: 15328155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple levels of activation of murine CD8(+) intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation.
    Wang HC; Klein JR
    J Immunol; 2001 Dec; 167(12):6717-23. PubMed ID: 11739485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. V gamma 9V delta 2 T cell response to colon carcinoma cells.
    Corvaisier M; Moreau-Aubry A; Diez E; Bennouna J; Mosnier JF; Scotet E; Bonneville M; Jotereau F
    J Immunol; 2005 Oct; 175(8):5481-8. PubMed ID: 16210656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.
    Kloss M; Decker P; Baltz KM; Baessler T; Jung G; Rammensee HG; Steinle A; Krusch M; Salih HR
    J Immunol; 2008 Nov; 181(10):6711-9. PubMed ID: 18981088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of costimulatory molecules (4-1BBL and Fas) and major histocompatibility class I chain-related A (MICA) in aortic tissue with Takayasu's arteritis.
    Seko Y; Sugishita K; Sato O; Takagi A; Tada Y; Matsuo H; Yagita H; Okumura K; Nagai R
    J Vasc Res; 2004; 41(1):84-90. PubMed ID: 14752253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas.
    Shiraki K; Tsuji N; Shioda T; Isselbacher KJ; Takahashi H
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6420-5. PubMed ID: 9177233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.
    Bergmann-Leitner ES; Abrams SI
    J Immunol; 2000 May; 164(9):4941-54. PubMed ID: 10779805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.